Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology

Aydin, 2013, Copeptin adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus, Peptides, 47, 66, 10.1016/j.peptides.2013.07.001 Aydin, 2013, Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle, Peptides, 52, 68, 10.1016/j.peptides.2013.11.024 Aydin, 2013, Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45min of a Turkish bath or running, Peptides, 50, 13, 10.1016/j.peptides.2013.09.011 Boström, 2012, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, Nature, 481, 463, 10.1038/nature10777 Choi, 2013, Serum irisin levels in new-onset type 2 diabetes, Diabetes Res Clin Pract, 100, 96, 10.1016/j.diabres.2013.01.007 Cicek, 2013, Does hepcidin play a role in the pathogenesis of aphthae in Behçet's disease and recurrent aphthous stomatitis?, J Eur Acad Dermatol Venereol, 10.1111/jdv.12326 Ebert, 2014, Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery, Cytokine, 65, 153, 10.1016/j.cyto.2013.11.009 Gröschl, 2001, Identification of leptin in human saliva, J Clin Endocrinol Metab, 86, 5234, 10.1210/jcem.86.11.7998 Hee Park, 2013, Circulating irisin in relation to insulin resistance and the metabolic syndrome, J Clin Endocrinol Metab, 98, 4899, 10.1210/jc.2013-2373 Hofmann, 2014, Irisin as a muscle-derived hormone stimulating thermogenesis – a critical update, Peptides, 54, 89, 10.1016/j.peptides.2014.01.016 Hsu, 1981, Use of avidin–biotin-peroxidase complex (ABC) inimmunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J Histochem Cytochem, 29, 577, 10.1177/29.4.6166661 Huh, 2012, FNDC5 and irisin in humans. I. Predictors of circulating concentrations in serum and plasma and II mRNA expression and circulating concentrations in response to weight loss and exercise, Metabolism, 61, 1725, 10.1016/j.metabol.2012.09.002 Kuloglu, 2014, Irisin: a potentially candidate marker for myocardial infarction, Peptides, 55, 85, 10.1016/j.peptides.2014.02.008 Lamy, 2012, Saliva proteomics as an emerging, non-invasive tool to study livestock physiology, nutrition and diseases, J Proteomics, 75, 4251, 10.1016/j.jprot.2012.05.007 Lantini, 1998, Immunocytochemical investigation of the subcellular distribution of some secretory products in human salivary glands, Eur J Morphol, 36, 230 Lantini, 2001, Subcellular localization of epidermal growth factor in human parotid gland, Histochem J, 33, 427, 10.1023/A:1013780028887 Lewandrowski, 2002, Cardiac markers for myocardial infarction. A brief review, Am J Clin Pathol, 118, 93 Li, 2011, Expression of ghrelin in human salivary glands and its levels in saliva and serum in Chinese obese children and adolescents, Arch Oral Biol, 56, 389, 10.1016/j.archoralbio.2010.10.014 Liu, 2014, Relationship between circulating irisin, renal function and body composition in type 2 diabetes, J Diabetes Complications, 28, 208, 10.1016/j.jdiacomp.2013.09.011 Liu, 2013, Lower circulating irisin is associated with type 2 diabetes mellitus, J Diabetes Complications, 27, 365, 10.1016/j.jdiacomp.2013.03.002 Moreno-Navarrete, 2013, Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance, J Clin Endocrinol Metab, 98, 769, 10.1210/jc.2012-2749 Ozbay, 2008, Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease, BMB Rep, 41, 55, 10.5483/BMBRep.2008.41.1.055 Piya, 2014, The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes, Am J Physiol Endocrinol Metab, 306, 512, 10.1152/ajpendo.00308.2013 Polyzos, 2014, Irisin in patients with nonalcoholic fatty liver disease, Metabolism, 63, 207, 10.1016/j.metabol.2013.09.013 Roca-Rivada, 2013, FNDC5/irisin is not only a myokine but also an adipokine, PLoS ONE, 8, 60563, 10.1371/journal.pone.0060563 Sanchis-Gomar, 2012, Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes, J Diabetes, 4, 196, 10.1111/j.1753-0407.2012.00194.x Stengel, 2013, Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – correlation with body mass index, Peptides, 39, 125, 10.1016/j.peptides.2012.11.014 Vamvini, 2013, Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans, Eur J Endocrinol, 169, 829, 10.1530/EJE-13-0276 Zhang, 2013, Salivary proteomics in biomedical research, Clin Chim Acta, 415, 261, 10.1016/j.cca.2012.11.001 Zhang, 2013, Irisin is inversely associated with intrahepatic triglyceride contents in obese adults, J Hepatol, 59, 557, 10.1016/j.jhep.2013.04.030